Amniotic membrane extract eye drops for ocular surface diseases: use and clinical outcome in real-world practice

[1]  R. Casaroli-Marano,et al.  Current clinical application of sclera and amniotic membrane for ocular tissue bio-replacement , 2020, Cell and Tissue Banking.

[2]  A. Carnevali,et al.  Umbilical Cord Blood and Serum for the Treatment of Ocular Diseases: A Comprehensive Review , 2020, Ophthalmology and Therapy.

[3]  S. Tseng,et al.  Basic science review of birth tissue uses in ophthalmology , 2020, Taiwan journal of ophthalmology.

[4]  C. Baudouin,et al.  Autologous Serum Eye Drops versus Artificial Tear Drops for Dry Eye Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2019, Ophthalmic Research.

[5]  I. Pluvy,et al.  Can the amniotic membrane be used to treat peripheral nerve defects? A review of literature. , 2019, Hand surgery & rehabilitation.

[6]  Jonathan D. Solomon,et al.  Safety and efficacy of amniotic cytokine extract in the treatment of dry eye disease , 2019, Clinical ophthalmology.

[7]  Mitchell P. Weikert,et al.  Autologous Serum-Based Eye Drops for Treatment of Ocular Surface Disease: A Report by the American Academy of Ophthalmology. , 2019, Ophthalmology.

[8]  H. Dua,et al.  Neurotrophic keratopathy , 2018, Progress in Retinal and Eye Research.

[9]  M. Moshirfar,et al.  Amniotic membrane extract and eye drops: a review of literature and clinical application , 2018, Clinical ophthalmology.

[10]  Mujtaba A. Qazi,et al.  Treatment outcomes in the DRy Eye Amniotic Membrane (DREAM) study , 2018, Clinical ophthalmology.

[11]  Marzieh Ebrahimi,et al.  The role of amniotic membrane extract eye drop (AMEED) in in vivo cultivation of limbal stem cells. , 2018, The ocular surface.

[12]  E. Campos,et al.  Blood derived eye drops for the treatment of cornea and ocular surface diseases. , 2017, Transfusion and Apheresis Science.

[13]  A. Lambiase,et al.  Neurotrophic factors and corneal nerve regeneration , 2017, Neural regeneration research.

[14]  R. Dana,et al.  TFOS DEWS II Management and Therapy Report. , 2017, The ocular surface.

[15]  K. Jirsova,et al.  Amniotic membrane in ophthalmology: properties, preparation, storage and indications for grafting—a review , 2017, Cell and Tissue Banking.

[16]  S. Tseng,et al.  Topical Cryopreserved Amniotic Membrane and Umbilical Cord Eye Drops Promote Re-Epithelialization in a Murine Corneal Abrasion Model. , 2017, Investigative Ophthalmology and Visual Science.

[17]  B. Seitz,et al.  Growth Factor and Interleukin Concentrations in Amniotic Membrane-Conditioned Medium , 2017, Current eye research.

[18]  U. Yilmaz,et al.  Comparison of Autologous Serum Versus Preservative Free Artificial Tear in Patients with Dry Eyes Due to Systemic Isotretinoin Therapy , 2017, Current eye research.

[19]  D. Berglund,et al.  Improving the anti‐inflammatory effect of serum eye drops using allogeneic serum permissive for regulatory T cell induction , 2015, Acta ophthalmologica.

[20]  B. Jeng,et al.  Blood-derived topical therapy for ocular surface diseases , 2015, British Journal of Ophthalmology.

[21]  P. Asbell,et al.  The Core Mechanism of Dry Eye Disease Is Inflammation , 2014, Eye & contact lens.

[22]  A. Jain,et al.  Human amniotic membrane transplantation: Different modalities of its use in ophthalmology. , 2014, World journal of transplantation.

[23]  A. Romphruk,et al.  Contamination Risk of 100% Autologous Serum Eye Drops in Management of Ocular Surface Diseases , 2013, Cornea.

[24]  A. Russo,et al.  The effects of different preservation processes on the total protein and growth factor content in a new biological product developed from human amniotic membrane , 2011, Cell and Tissue Banking.

[25]  Zuguo Liu,et al.  Amniotic membrane extraction solution for ocular chemical burns , 2009, Clinical & experimental ophthalmology.

[26]  H. Shahriari,et al.  Comparison of the Effect of Amniotic Membrane Suspension and Autologous Serum on Alkaline Corneal Epithelial Wound Healing in the Rabbit Model , 2008, Cornea.

[27]  T. Wedel,et al.  [Epitheliotrophic capacity of serum eye drops from healthy donors versus serum from immunosuppressed patients with rheumatoid arthritis]. , 2008, Klinische Monatsblatter fur Augenheilkunde.

[28]  A. Lia,et al.  Suspension Made with Amniotic Membrane: Clinical Trial , 2005, European journal of ophthalmology.

[29]  D. Tan,et al.  Kinetic Analysis of Conjunctival Epithelial Wound Healing in the Rabbit Model , 2005 .

[30]  A. Bron,et al.  Grading Of Corneal and Conjunctival Staining in the Context of Other Dry Eye Tests , 2003, Cornea.

[31]  K. Tsubota,et al.  Treatment of persistent corneal epithelial defect by autologous serum application. , 1999, Ophthalmology.